1. Guo, Yulin, Cao, Feng, Hu, Shun, Li, Ang, Li, Fei. . TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. In Discovery medicine, 30, 145-153. doi:. https://pubmed.ncbi.nlm.nih.gov/33593482/
2. Guo, Siyu, Liu, Xinkui, Zhang, Jingyuan, Zhou, Wei, Wu, Jiarui. 2023. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer. In Computers in biology and medicine, 161, 107066. doi:10.1016/j.compbiomed.2023.107066. https://pubmed.ncbi.nlm.nih.gov/37263064/
3. Sirkis, Daniel W, Warly Solsberg, Caroline, Johnson, Taylor P, Geier, Ethan G, Yokoyama, Jennifer S. 2023. Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy. In Genome medicine, 15, 53. doi:10.1186/s13073-023-01205-3. https://pubmed.ncbi.nlm.nih.gov/37464408/
4. Li, Hongxia, Yang, Weili, Zhang, Meiying, Hu, Liming, Guo, Mingzhou. 2021. Methylation of TMEM176A, a key ERK signaling regulator, is a novel synthetic lethality marker of ATM inhibitors in human lung cancer. In Epigenomics, 13, 1403-1419. doi:10.2217/epi-2021-0217. https://pubmed.ncbi.nlm.nih.gov/34558311/
5. Li, Hongxia, Zhang, Meiying, Linghu, Enqiang, Hu, Liming, Guo, Mingzhou. 2018. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma. In Clinical epigenetics, 10, 137. doi:10.1186/s13148-018-0570-4. https://pubmed.ncbi.nlm.nih.gov/30400968/
6. Gao, Dan, Han, Yingjie, Yang, Yang, Lu, Zhi John, Guo, Mingzhou. 2017. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development. In Epigenetics, 12, 575-583. doi:10.1080/15592294.2017.1341027. https://pubmed.ncbi.nlm.nih.gov/28678648/
7. Cuajungco, Math P, Podevin, William, Valluri, Vinod K, Nguyen, Van H, Taylor, Katrina. 2012. Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology. In Acta histochemica, 114, 705-12. doi:10.1016/j.acthis.2011.12.006. https://pubmed.ncbi.nlm.nih.gov/22244448/
8. Wang, Yunhui, Ji, LiKang, Ji, Chunfeng, Wang, Fan. 2023. Multi-omics approaches establishing histone modification based prognostic model in glioma patients and further verification of the carcinogenesis mechanism. In Functional & integrative genomics, 23, 307. doi:10.1007/s10142-023-01229-3. https://pubmed.ncbi.nlm.nih.gov/37730879/
智鼠故事 
